Microwave Ablation of Uterine Fibroids

Prospective Observational Study of Microwave Ablation of Uterine Fibroids (MyoMwa)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07780019

Acronym

MyoMwa

Enrollment

100

Registered

2026-08-21

Start date

2026-05-01

Completion date

2034-12-01

Last updated

2026-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uterine Fibroids (Leiomyoma)

Keywords

microwave ablation

Brief summary

This prospective observational study aims to evaluate the effectiveness and acceptability of percutaneous or vaginal ultrasound guided microwave ablation for the treatment or symptomatic uterine fibroids. We will include 100 women.

Interventions

PROCEDUREmicrowave ablation

ultrasound guided percutaneus microwave ablation

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 56 Years

Healthy volunteers

Inclusion criteria

* symptomatic fibroids * premenopausal status * acceptable risks for general anestesia or sedation * willing to undergo mwa treatment and participate in the study

Exclusion criteria

* postmenopausal status * bleeding disorder with increased risk of bleeding

Design outcomes

Primary

Measure	Time frame	Description
Symptom severity of uterine fibroids and quality of life	12 months	Score of validated form Uterine Fibroid symptom - Quality of life questinnaire. minimum 0, maximum 100 where higher scores indicate higher symptom severity
suitability of mwa for general fibroid population	12 months	objective and subjective outcome of mwa in different fibroid types, sizes and locations

Countries

Finland

Contacts

PRINCIPAL_INVESTIGATORKirsi Joronen

Turku University Hospital

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 22, 2026